Literature DB >> 8807048

New model of oropharyngeal and gastrointestinal colonization by Candida albicans in CD4+ T-cell-deficient mice for evaluation of antifungal agents.

A M Flattery1, G K Abruzzo, C J Gill, J G Smith, K Bartizal.   

Abstract

A new model for the evaluation of antifungal compounds against oropharyngeal and gastrointestinal mucosal colonization by Candida albicans was developed. To simulate the immune deficiency observed in AIDS patients, mice were depleted of CD4+ T lymphocytes by the injection of either GK1.5 hybridoma cells or purified anti-CD4+ T lymphocytes by the injection of either GK1.5 hybridoma cells or purified anti-CD4+ monoclonal antibody derived from GK1.5 hybridoma cells in tissue culture. Fluorescence-activated cell sorter analysis of splenic lymphocytes confirmed the elimination of the CD4+ T-cell population. Gentamicin, a broad-spectrum, nonabsorbable aminoglycoside antibiotic, was given via the drinking water to reduce the normal gastrointestinal microflora, allowing less competition for colonization of the gastrointestinal tract by the C. albicans isolates. Mice were challenged by gavage and swabbing their oral mucosae with a pure culture of C. albicans. Gentamicin was withdrawn 3 days postchallenge, and antifungal compounds were administered via the drinking water ad libitum at concentrations ranging from 25 to 400 micrograms/ml. L-693989, a water-soluble phosphorylated cyclic lipopeptide prodrug of pneumocandin Bo, and L-733560, a semisynthetic derivative of pneumocandin Bo, are inhibitors of 1,3-beta-D-glucan synthesis that exhibit potent in vivo anti-Candida spp. and anti-Pneumocystis carinii activities. The efficacies of L-693989, L-733560, fluconazole, ketoconazole, and nystatin were evaluated in this new oropharyngeal and gastrointestinal model of mucosal colonization. L-693989, L-733560, fluconazole, and ketoconazole showed superior efficacies in reducing the numbers of C. albicans CFU per gram of feces and the numbers of oral CFU relative to those in sham-treated controls in this model, while nystatin was moderately effective in reducing oral and fecal colonization by C. albicans in this model.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807048      PMCID: PMC163381     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

Review 1.  Current concepts. Treatment of infections associated with human immunodeficiency virus.

Authors:  A E Glatt; K Chirgwin; S H Landesman
Journal:  N Engl J Med       Date:  1988-06-02       Impact factor: 91.245

Review 2.  Oral candidiasis: pathogenesis and host defense.

Authors:  J B Epstein; E L Truelove; K T Izutzu
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

3.  Immunity to Candida albicans.

Authors:  T J Rogers; E Balish
Journal:  Microbiol Rev       Date:  1980-12

Review 4.  Esophageal candidiasis. Managing an increasingly prevalent infection.

Authors:  T J Walsh; S R Hamilton; N Belitsos
Journal:  Postgrad Med       Date:  1988-08       Impact factor: 3.840

5.  Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality.

Authors:  F Meunier-Carpentier; T E Kiehn; D Armstrong
Journal:  Am J Med       Date:  1981-09       Impact factor: 4.965

6.  Use of anti-CD4+ hybridoma cells to induce Pneumocystis carinii in mice.

Authors:  D C McFadden; M A Powles; J G Smith; A M Flattery; K Bartizal; D M Schmatz
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

7.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency.

Authors:  M S Gottlieb; R Schroff; H M Schanker; J D Weisman; P T Fan; R A Wolf; A Saxon
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

8.  Dissemination of yeasts after gastrointestinal inoculation in antibiotic-treated mice.

Authors:  M J Kennedy; P A Volz
Journal:  Sabouraudia       Date:  1983-03

9.  Effects of compromising agents on candidosis in mice with persistent infections initiated in infancy.

Authors:  M N Guentzel; C Herrera
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

10.  Mammary gland contamination as a means of establishing long-term gastrointestinal colonization of infant mice with Candida albicans.

Authors:  R F Hector; J E Domer
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

View more
  2 in total

1.  Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs.

Authors:  Karl V Clemons; Gloria M Gonzalez; Gaurav Singh; Jackie Imai; Marife Espiritu; Rachana Parmar; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

2.  New model of oropharyngeal candidiasis in mice.

Authors:  Y Kamai; M Kubota; Y Kamai; T Hosokawa; T Fukuoka; S G Filler
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.